Measurements of PD-1, PD-L1 and PD-L2 also may be affected by glycosylation, which has been reported for PD-L1 in breast cancer cells (29) and by proteolysis of PD-L1 and PD-L2 by matrix metalloproteinases (30). Here, PDCD1LG2 is linked to breast carcinoma.